These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 38770189)

  • 1. SARS-CoV-2 surveillance in a veterinary health system provides insight into transmission risks.
    Sparrer MN; Hodges NF; Ragan I; Yamashita T; Reed KJ; Sherman TJ; Mayer T; Maichak C; Adney DR; Carpenter M; Webb TL; Mayo C
    J Am Vet Med Assoc; 2024 Jan; 262(1):93-99. PubMed ID: 38103381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigation of SARS-CoV-2 Infection among Companion Animals in Households with Confirmed Human COVID-19 Cases.
    Venkat H; Yaglom HD; Hecht G; Goedderz A; Ely JL; Sprenkle M; Martins T; Jasso-Selles D; Lemmer D; Gesimondo J; Ruberto I; Komatsu K; Engelthaler DM
    Pathogens; 2024 Jun; 13(6):. PubMed ID: 38921764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emergence and fixation of SARS-CoV-2 minority variants in a chronically infected patient receiving therapy in Denmark.
    Fonager J; Nytofte NJS; Schouw CH; Poulsen CB; Wiese L; Fomsgaard A; Bennedbæk M; Rasmussen M; Nielsen XC
    APMIS; 2024 Jul; ():. PubMed ID: 38961316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SARS-CoV-2 Seroepidemiology and Antibody Levels in Children during BA.5 Predominance Period.
    Filippatos F; Tatsi EB; Dourdouna MM; Zoumakis E; Margeli A; Syriopoulou V; Michos A
    Diagnostics (Basel); 2024 May; 14(10):. PubMed ID: 38786337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Biological Functions and Clinical Significance of SARS-CoV-2 Variants of Corcern.
    Akkız H
    Front Med (Lausanne); 2022; 9():849217. PubMed ID: 35669924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evolution of the SARS-CoV-2 omicron variants BA.1 to BA.5: Implications for immune escape and transmission.
    Shrestha LB; Foster C; Rawlinson W; Tedla N; Bull RA
    Rev Med Virol; 2022 Sep; 32(5):e2381. PubMed ID: 35856385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sero-epidemiological investigation and cross-neutralization activity against SARS-CoV-2 variants in cats and dogs, Thailand.
    Suwanpakdee S; Ketchim N; Thongdee M; Chaiwattanarungruengpaisan S; Tangsudjai S; Wiriyarat W; Julapanthong P; Trakoolchaisri W; Buamas S; Sakcamduang W; Okada PA; Puthavathana P; Paungpin W
    Front Vet Sci; 2024; 11():1329656. PubMed ID: 38770189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased breadth and neutralization of antibodies against SARS-CoV-2 variants after infection and vaccination: A serosurveillance study in pediatric patients of Southern Switzerland.
    Mazzara C; Bassi J; Silacci-Fregni C; Muoio F; Passini N; Corti D; Simonetti GD; Vanoni F; Kottanattu L; Piccoli L
    Eur J Pediatr; 2024 Mar; 183(3):1425-1434. PubMed ID: 38175262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pre-Omicron Vaccine Breakthrough Infection Induces Superior Cross-Neutralization against SARS-CoV-2 Omicron BA.1 Compared to Infection Alone.
    da Silva ES; Kohnen M; Gilson G; Staub T; Arendt V; Hilger C; Servais JY; Charpentier E; Domingues O; Snoeck CJ; Ollert M; Seguin-Devaux C; Perez-Bercoff D
    Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SARS-CoV-2 Antibodies in Commercial Immunoglobulin Products Show Markedly Reduced Cross-reactivities Against Omicron Variants.
    Lindahl H; Chen P; Åberg M; Ljunggren HG; Buggert M; Aleman S; Smith CIE; Bergman P
    J Clin Immunol; 2023 Aug; 43(6):1075-1082. PubMed ID: 37058198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibody-dependent NK-cell and neutralizing antibody responses against the Spike protein of Wuhan-Hu-1 and Omicron BA.1 SARS-CoV-2 variants in vaccinated experienced and vaccinated naïve individuals.
    Albert E; Fernández-Soto D; Giménez E; Casanovas JM; Zulaica J; Álvarez-Rodríguez B; Rusu L; Geller R; Reyburn HT; Navarro D
    J Med Virol; 2023 Jul; 95(7):e28900. PubMed ID: 37403730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neutralizing Antibodies against the SARS-CoV-2 Ancestral Strain and Omicron BA.1 Subvariant in Dogs and Cats in Mexico.
    Dehesa-Canseco F; Pastrana-Unzueta R; Carrillo-Guzmán N; Liljehult-Fuentes F; Pérez-De la Rosa JD; Ramírez-Mendoza H; Estrada-Franco JG; Navarro-López R; Hernández J; Solís-Hernández M
    Pathogens; 2023 Jun; 12(6):. PubMed ID: 37375525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SARS-CoV-2 Seroprevalence and Cross-Variant Antibody Neutralization in Cats, United Kingdom.
    Tyson GB; Jones S; Logan N; McDonald M; Marshall L; Murcia PR; Willett BJ; Weir W; Hosie MJ
    Emerg Infect Dis; 2023 Jun; 29(6):1223-1227. PubMed ID: 37141617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SARS-CoV-2-Neutralizing Antibody Response and Correlation of Two Serological Assays with Microneutralization.
    Souiri A; Lemriss S; El Maliki B; Falahi H; El Fahime E; El Kabbaj S
    Vaccines (Basel); 2023 Mar; 11(3):. PubMed ID: 36992173
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.